Correlation between adiponectin rs2241766 and rs266729 polymorphisms and risk of papillary thyroid cancer

About 60-80% of thyroid cancer (TC) cases are papillary thyroid cancer (PTC). Studies have shown that serum adiponectin levels are inversely related to the risk of TC and PTC. Aim of the present study was to evaluate the association between adiponectin rs2241766 and rs266729 polymorphisms and risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Maleki, Mohsen, Karajibani, Mansour, Sarvani, Mohsen, Montazerifar, Farzaneh, Salimi, Saeedeh, Heidari6, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shiraz University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661673/
https://www.ncbi.nlm.nih.gov/pubmed/36718238
http://dx.doi.org/10.22099/mbrc.2022.43012.1714
Descripción
Sumario:About 60-80% of thyroid cancer (TC) cases are papillary thyroid cancer (PTC). Studies have shown that serum adiponectin levels are inversely related to the risk of TC and PTC. Aim of the present study was to evaluate the association between adiponectin rs2241766 and rs266729 polymorphisms and risk of PTC. 122 PTC patients and 128 healthy subjects were enrolled in the study. PCR-RFLP and ARMS-PCR methods were used for genotype analysis. The rs266729 polymorphism did not correlate with risk of PTC. As regard rs2241766 polymorphism, the frequency of the GG genotype did not have a significant difference between the two groups, although, PTC cases showed higher frequency of GT genotype compared to controls (OR=2.87, 95% CI=1.56-5.28, P=0.001). We observed a significant association between adiponectin rs2241766 polymorphism and PTC, however, our result showed no significant relationship between adiponectin rs266729 polymorphism and risk of PTC.

Ejemplares similares